Rajesh Jain
30Patents
9h-index
21Co-inventors
75Inventor score
Filing activity: Jun 13, 1996 → Sep 29, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5858371A | Pharmaceutical composition for the control and treatment of anorectal and colonic diseases | Human Necessities | 134 | Expired |
| US7122198B1 | Fast dissolving composition with prolonged sweet taste | Human Necessities | 66 | Expired |
| US6258816A | Anti-allergy anti-inflammatory composition | Human Necessities | 64 | Expired |
| US6187747A | Pharmaceutical composition comprising cyclosporin | Human Necessities | 32 | Expired |
| US6008191A | Pharmaceutical compositions containing cyclosporin | Human Necessities | 26 | Expired |
| US5716609A | Therapeutic anti-inflammatory and analgesic composition containing nimesulide for use transdermally and a process for the manufacture thereof | Human Necessities | 25 | Expired |
| US6346511B1 | Pharmaceutical composition comprising cyclosporin | Human Necessities | 22 | Expired |
| US6017932A | Pharmaceutical compositions containing at least one NSAID having increased bioavailability | Human Necessities | 15 | Expired |
| US5945398A | Pharmaceutical compositions containing cyclosporin | Human Necessities | 11 | Expired |
| US9292423B1 | Monitoring applications for compatibility issues | Physics | 7 | Active |
| US5688829A | Therapeutic injectable analgesic composition containing nimesulide and a process for the manufacture thereof | Human Necessities | 3 | Expired |
| US7195769B2 | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation | Human Necessities | 3 | Expired |
| US9018249B2 | SGLT inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8551451B2 | Combination vaccine with acellular pertussis | Emerging Cross-Sectional Technologies | 1 | Active |
| US8906913B2 | Azabicyclohexanes | Chemistry; Metallurgy | 1 | Active |
| US6306838A | Targeted vesicular constructs for cyto protection and treatment of h. pylori | Human Necessities | 1 | Expired |
| US11123420B2 | Stable live attenuated recombinant dengue vaccine | Emerging Cross-Sectional Technologies | 1 | Active |
| US9133116B2 | Bicyclic compounds | Human Necessities | 1 | Active |
| US9642808B2 | Extended release compositions comprising mycophenolate sodium and processes thereof | Human Necessities | 1 | Active |
| US6451302B1 | Parenteral water-miscible non-intensely colored injectable composition of non-steroidal anti-inflammatory drugs | Human Necessities | 0 | Expired |
| US7371412B2 | Pharmaceutical compositions comprising an extract of Euphorbia prostrata | Human Necessities | 0 | Expired |
| US6576625B2 | Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections | Human Necessities | 0 | Expired |
| US6160019A | Parenteral water-miscible non intensely colored injectable composition of non-steroidal anti-inflammatory drugs | Human Necessities | 0 | Expired |
| US7956067B2 | Composition comprising at least one higher aliphatic alcohol and an extract of Griffonia simplicifolia | Human Necessities | 0 | Active |
| US9974489B2 | Monitoring device and system for providing an alert when an infant is unresponsive to stimulus | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.